Response to ischemia and endogenous myocardial protection in the diabetic heart

Advances in Experimental Medicine and Biology

Volumn 498, Issue , 2001, Pages 285-293

  Ravingerova, Tanya ^a   Stetka, Radovan ^a   Barancik, Miroslav ^a   Volkovova, Katarina ^a   Pancza, Dezider ^a   Ziegelhöffer, Attila ^a   Styk, Jan ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOMYOPATHY; CHRONIC DISEASE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; HEART ARRHYTHMIA; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALIA;

EID: 0035698977     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-1321-6_36     Document Type: Conference Paper

References (28)

1. Diabetes and cardiovascular risk factors. The Framingham study
2. Altered myocardial mechanics in diabetic rats
3. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy
4. + exchange during ischemia and reperfusion of normal and diabetic rat hearts
5. + exchange in cardiac sarcolemmal vesicles isolated from diabetic rats
6. Calcium movements in relation to heart function
7. Myocardial ischemia, reperfusion and cytoprotection
8. The diabetic heart is more sensitive to ischemic injury
9. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
10. Preconditioning against infarction in rat heart does not involve pertussis toxin sensitive G protein
11. Preconditioning induced protection against postischemic contractile dysfunction: Characteristics and mechanisms
12. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats
13. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts
14. Protection afforded by preconditioning in the diabetic heart against ischemic injury
15. The Lambeth conventions: Guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion
16. Brief, intermediate and prolonged ischemia in the crystalloid perfused rat heart: Relationship between susceptibility to arrhythmias and degree of ultrastructural injury
17. Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischemia-induced ventricular fibrillation
18. 2+ metabolism
19. Controversies on the sensitivity of the diabetic heart to ischemic injury: The sensitivity of the diabetic heart to ischemic injury is decreased
20. Experimental diabetes is associated with functional activation of protein kinase C and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade
21. Myocardial substrate metabolism: Implications for diabetic cardiomyopathy
22. Ischemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: Implications for the mechanisms of initiation and maintenance of ventricular fibrillation
23. Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats
24. Preconditioning of isolated rat heart is mediated by protein kinase C
25. Blockade of ATP-sensitive potassium channel prevents myocardial preconditioning in dogs
26. Myocardial protection in ischemia and reperfusion
27. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment
28. Energy metabolisms after ischemic preconditioning in streptozotocin-induced diabetic rat hearts